Evaluating Patients With Impaired Hepatic Function
NCT00398424
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Impaired Hepatic Function
Interventions
DRUG:
S-1/Cisplatin
Sponsor
Taiho Oncology, Inc.